Latest Research in Cancer-related molecular mechanisms research
14 research papers · 2026 median publication year
Top Research Topics in Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research — 2 papers
- Single-cell and spatial transcriptomics — 2 papers
- Cancer Cells and Metastasis — 2 papers
- Cancer-related Molecular Pathways — 1 papers
- Antimicrobial Peptides and Activities — 1 papers
- Circadian rhythm and melatonin — 1 papers
- Signaling Pathways in Disease — 1 papers
- RNA modifications and cancer — 1 papers
- Cancer Immunotherapy and Biomarkers — 1 papers
- Immune cells in cancer — 1 papers
Highest-Cited Papers
- The role of LncRNA FOXD3-AS1 in multiple human malignancies
- p53—Oncogene, Tumor Suppressor Gene, Guardian of the Genome and the Cell
- Integrative analysis of lncRNA-miRNA-mRNA expression profiles in esophageal squamous cell carcinoma tissues
- Cathelicidin LL-37 inhibits angiogenesis and migration in gastric cancer via inhibition of NF-κB/IL-6 signaling.
- Prognostic value of melatonin-related signature genes in lung adenocarcinoma
- A serpin–myeloid axis in pancreatic cancer heterogeneity and immune evasion
- Transmembrane glycoprotein BSG serves a dual role as a prognostic and immunological modulator in the tumor microenvironment of lung adenocarcinoma
- ZC3H13-driven m6A methylation of P4HA3 enhances gastric cancer tumorigenesis via interacting with IGF2BP1
- Tumor-intrinsic IFNγ signaling and niche adaptation drive early colonization in ovarian cancer metastasis
- Gastric cancer tertiary lymphoid structures in the muscularis propria are associated with therapy resistance and promote immunosuppression
- Stroma-Dominant Colorectal Cancer Harbors CAF-Rich Spatial Architecture and EMT-Associated Cancer Cell Plasticity Detectable After Dissemination
- Signal Transducing Adaptor Protein‐2 Represses Epithelial‐Mesenchymal Transition by Downregulating SMAD ‐Mediated ZEB1 Expression
- LTBP4 deficiency induces MRC1 + /CD44 + macrophages to drive cancer progression in preclinical colorectal cancer models
- Overexpression of KRAS-Q25A mutant with enhanced GTPase activity inhibits the progression of KRAS-G12D colorectal cancer